UBS AM’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,111,231	Closed	-$129M	–	2641
2023 Q3	$129M	Buy	1,111,231 +83,525	+8%	+$8.97M	0.06%	348
2023 Q2	$112M	Hold	1,027,706	–	–	0.05%	363
2023 Q1	$112M	Buy	1,027,706 +20,476	+2%	+$2.26M	0.05%	363
2022 Q4	$115M	Buy	1,007,230 +22,248	+2%	+$1.85M	0.06%	352
2022 Q3	$61M	Buy	+984,982	New	+$68.8M	0.03%	487
2019 Q2	–	Sell	-131,561	Closed	-$3.48M	–	2910
2019 Q1	$3.48M	Buy	131,561 +8,386	+7%	+$199K	﹤0.01%	1283
2018 Q4	$2.41M	Buy	123,175 +15,227	+14%	+$298K	﹤0.01%	1362
2018 Q3	$2.11M	Buy	107,948 +3,182	+3%	+$60.5K	﹤0.01%	1482
2018 Q2	$1.73M	Sell	104,766 -9,952	-9%	-$152K	﹤0.01%	1570
2018 Q1	$1.63M	Buy	114,718 +10,694	+10%	+$158K	﹤0.01%	1561
2017 Q4	$1.52M	Buy	104,024 +10,780	+12%	+$151K	﹤0.01%	1554
2017 Q3	$1.18M	Buy	93,244 +5,104	+6%	+$64.9K	﹤0.01%	1635
2017 Q2	$1.05M	Sell	88,140 -91,238	-51%	-$1.13M	﹤0.01%	1639
2017 Q1	$2.65M	Sell	179,378 -65,155	-27%	-$1.06M	﹤0.01%	1233
2016 Q4	$3.96M	Sell	244,533 -461,399	-65%	-$8.37M	﹤0.01%	1047
2016 Q3	$12.8M	Sell	705,932 -13,252	-2%	-$259K	0.01%	823
2016 Q2	$11.8M	Buy	719,184 +231,170	+47%	+$3.74M	0.01%	839
2016 Q1	$8.09M	Buy	488,014 +388,001	+388%	+$6.79M	0.01%	895
2015 Q4	$2.17M	Buy	100,013 +17,173	+21%	+$334K	﹤0.01%	1407
2015 Q3	$1.64M	Buy	82,840 +7,256	+10%	+$229K	﹤0.01%	1515
2015 Q2	$2.63M	Buy	75,584 +27,184	+56%	+$830K	﹤0.01%	1280
2015 Q1	$1.26M	Buy	48,400 +13,600	+39%	+$249K	﹤0.01%	1546
2014 Q4	$449K	Buy	34,800 +5,200	+18%	+$65.1K	﹤0.01%	2002
2014 Q3	$363K	Buy	29,600 +16,100	+119%	+$187K	﹤0.01%	2036
2014 Q2	$214K	Buy	+13,500	New	+$193K	﹤0.01%	2379

Other funds holding HZNP